Vincerx Pharma, Inc. (VINC)
OTCMKTS · Delayed Price · Currency is USD
0.0549
-0.0021 (-3.68%)
At close: Jul 23, 2025

Vincerx Pharma Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 2021FY 20202020
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2020
Net Income
-22.65-30.07-40.16-62.98-39.31-16.62
Upgrade
Depreciation & Amortization
0.831.090.920.940.34-
Upgrade
Other Amortization
-----0.02
Upgrade
Asset Writedown & Restructuring Costs
-----5
Upgrade
Loss (Gain) From Sale of Investments
-0.21-0.21-0.63-0.29--
Upgrade
Stock-Based Compensation
3.383.473.5610.0623.314.38
Upgrade
Other Operating Activities
-3.7-0.230.05-6.3-23.365.9
Upgrade
Change in Accounts Payable
-0.05-0.47-1.571.051.530.46
Upgrade
Change in Other Net Operating Assets
-0.450.29-2.62-2.074.08-1.42
Upgrade
Operating Cash Flow
-22.84-26.13-40.45-59.6-33.4-2.28
Upgrade
Capital Expenditures
-----0.26-
Upgrade
Sale (Purchase) of Intangibles
-----5-
Upgrade
Investment in Securities
0.210.2141.5-40.58--
Upgrade
Investing Cash Flow
0.210.2141.5-40.58-5.26-
Upgrade
Short-Term Debt Issued
-----0.3
Upgrade
Total Debt Issued
-----0.3
Upgrade
Short-Term Debt Repaid
------0.3
Upgrade
Total Debt Repaid
------0.3
Upgrade
Issuance of Common Stock
21.8417.990.110.2888.45-
Upgrade
Other Financing Activities
-----64.07
Upgrade
Financing Cash Flow
21.8417.990.110.2888.4564.07
Upgrade
Foreign Exchange Rate Adjustments
0.110.14-0.040.07-0.02-
Upgrade
Net Cash Flow
-0.67-7.791.12-99.8349.7761.79
Upgrade
Free Cash Flow
-22.84-26.13-40.45-59.6-33.66-2.28
Upgrade
Free Cash Flow Per Share
-9.06-13.77-37.98-56.69-39.19-8.68
Upgrade
Cash Interest Paid
----0.030.03
Upgrade
Levered Free Cash Flow
-15.87-12.24-24.29-40.13-44.46-
Upgrade
Unlevered Free Cash Flow
-15.87-12.24-24.29-40.13-44.46-
Upgrade
Change in Net Working Capital
4.5-1.372.148.1723.7-
Upgrade
Source: S&P Global Market Intelligence. Standard template. Financial Sources.